Details
Patients on multiple medications face increased risks of adverse drug events (ADEs), leading to higher rates of ER visits and hospital admissions. These polypharmacy patients drive a substantial portion of medical loss ratios, presenting unique and complex challenges for care teams.
In this session, we will explore how ACOs can implement a proactive strategy to identify and expertly manage their highest-risk polypharmacy patients. Tackling this critical issue improves patient outcomes, quality metric performance, and physician satisfaction—all while avoiding millions in unnecessary medical spend.
Key Learning Objectives:
- Recognize the impact of ADEs on quality and cost in value-based care.
- Identify proactive strategies to mitigate the risk of ADEs in polypharmacy patients.
- Understand how to seamlessly integrate predictive analytics and risk management into existing clinical workflows.
- Evaluate real-world use cases of ADE prevention and management within ACOs.
